Mundomedis FZCO and Arazy Group recently signed a cooperation memorandum. Both companies will cooperate to support Mundomedis’ global medical device portfolio companies by streamlining their global regulatory processes through Arazy Group’s Licensale online platform.
Mundomedis, the Dubai Silicon Oasis based global MedTech incubator for start-up and early-stage medical device companies actively invests in medical device companies and provides its’ portfolio companies access to investors. In addition, Mundomedis provides support services and access to global distribution channels, strategic partners and outsourcing partners while lowering monthly operating expenses and minimizing operational risks for its portfolio companies.
Arazy Group is a leading global MedTech Regulatory Affairs Technology company. When Arazy Group launched LICENSALE® – Global MedTech Registration System in 2013, they became the first company to offer advanced medical device registration and license management technology specifically for the medical and IVD device industry. LICENSALE® has since delivered thousands of new IVD and medical device registrations, amendments, renewals, and transfers of licenses, staying true to the company’s mission to make the best medical devices and medical practices available to patients and physicians world-wide.
Kai Trompeter, Mundomedis CEO, said, “Not only do we see enormous value for our portfolio companies in cooperating with Arazy Group, over the last months we have developed a close relationship with Benjamin Arazy, founder of Arazy Group and are discussing a multitude of additional cooperation opportunities. We believe that this cooperation is a significant next step to help establish Dubai as the new global MedTech innovation hub.”
Benjamin Arazy, Arazy Group CEO, said, “Mundomedis and Arazy Group’s combined expertise offers an excellent platform for MedTech companies seeking growth and rapid market access on a global scale. We are looking forward to expanding our involvement in Dubai and supporting the development of a worldwide MedTech hub in the coming years”.
For further information please visit the company’s websites:
